Lowell Blake & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.15M | Buy |
|
|||||
|
2023
Q2 | $2.39M | Sell |
|
|||||
|
2023
Q1 | $2.35M | Buy |
|
|||||
|
2022
Q4 | $1.88M | Hold |
|
|||||
|
2022
Q3 | $1.39M | Buy |
|
|||||
|
2022
Q2 | $1.51M | Sell |
|
|||||
|
2022
Q1 | $1.52M | Buy |
|
|||||
|
2021
Q4 | $1.34M | Sell |
|
|||||
|
2021
Q3 | $1.39M | Buy |
|
|||||
|
2021
Q2 | $1.17M | Buy |
|
|||||
|
2021
Q1 | $843K | Buy |
|
|||||
|
2020
Q4 | $275K | Buy |
|
|||||
|
2020
Q3 | $269K | Sell |
|
|||||
|
2020
Q2 | $266K | Buy |
|
|||||
|
2020
Q1 | $226K | Hold |
|
|||||
|
2019
Q4 | $217K | Buy |
|